United States Remote Hemodynamic Monitoring Systems Market Report 2017-2018: Analysis And Forecasts, Drivers And Limiters & Competitive Market Share Analysis
Comunicato Precedente
Comunicato Successivo
Heart failure occurs when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs. Changes in the pressure of blood through the pulmonary artery can be an indicator of heart failure or worsening heart failure. Following changes in blood pressure, heart failure will cause shortness of breath and weight gain. Heart failure is diagnosed by history of symptoms and a physical examination with confirmation echocardiology. Heart failure afflicts 2% of the adult population in developed nations, which increases to 6 to 10% for those above the age of 65. The highest risk of death is generally right after diagnosis, at around 35%.
Remote hemodynamic monitoring devices are implanted into the patient to monitor the blood pressure in the pulmonary artery. The device takes measurements from inside the body and transmits the data to a secure website for clinicians to review. The clinicians are then able to preemptively able to detect heart failure and treat them before symptoms arise.
Key Topics Covered:
Executive Summary
1. Research Methodology
2. Disease Overview
3. Product Portfolio
4. Remote Hemodynamic Monitoring System Market
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/research/8fg7jk/united_states?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
